News

Hepatocellular carcinoma (HCC) poses a substantial health burden globally, with liver cancer being the fourth most common cause of cancer-related mortality worldwide. In China, where the incidence of HCC is particularly high due to the prevalence of chronic hepatitis B virus (HBV) infection, the disease

Esophageal cancer, a highly aggressive malignancy originating in the esophageal epithelium, poses significant public health challenges in China, where it ranks sixth in incidence and fifth in mortality among cancers. The country’s large population contributes to over half of the global cases and deaths from

Osaka, Japan – Pancreatic cancer is an aggressive disease with few available treatments. Thankfully, researchers are hard at work to improve treatment options, and researchers from Japan have now unveiled something promising. In a study published this month in Cancer Science, researchers from Osaka University

HCV infection is the underlying cause for chronic Hepatitis C (CHC), liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases. Recent medical advancement made a new breakthrough treatment available for patients with hepatitis C. DAAs that

The rise in the incidence of oropharyngeal squamous cell carcinomas (OPSCCs) linked to human papillomavirus (HPV)-16 infection has become notable, surpassing cervical high-risk HPV infections by 2019. HPV-associated OPSCCs present a better prognosis compared to traditional oropharyngeal malignancies, largely due to lower correlations with chronic

Cancers of the digestive system mainly include esophageal, gastric, liver, gallbladder, pancreatic, and colorectal cancers. With an estimated 20 million new cases, colorectal cancer is the third most common cancer and the second leading cause of cancer-related deaths. Closely followed by gastric and liver cancers,

Natasha Sheybani, assistant professor of biomedical engineering at the University of Virginia School of Engineering, will collaborate with researchers at Children’s National Hospital to study the combination of two therapies for pediatric brain cancer.  Credit: UVA Engineering Natasha Sheybani, assistant professor of biomedical engineering at

Oral Leukoplakia (OLK) is recognized as a predominant potentially malignant oral epithelial lesion (PMOEL), posing significant risks due to its potential progression to oral squamous cell carcinoma (OSCC). OSCC, a major subset of head and neck cancers, accounts for a significant global health burden, especially

“Herein we discuss how gut microbiota and microbial metabolites regulate basal inflammation levels in the gut and the healing process of the bowel after surgery.” Credit: 2024 Hajjar et al. “Herein we discuss how gut microbiota and microbial metabolites regulate basal inflammation levels in the

SAN ANTONIO — August 19, 2024 —Southwest Research Institute (SwRI) has developed a unique technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases. Combining SwRI’s 3D drug screening software tool and machine learning techniques, SwRI scientists successfully predicted the DNA binding